TRIM29 anticorps (AA 309-588)
Aperçu rapide pour TRIM29 anticorps (AA 309-588) (ABIN6149518)
Antigène
Voir toutes TRIM29 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 309-588
-
Séquence
- ILEQNFRDLV RDLEKQKEEV RAALEQREQD AVDQVKVIMD ALDERAKVLH EDKQTREQLH SISDSVLFLQ EFGALMSNYS LPPPLPTYHV LLEGEGLGQS LGNFKDDLLN VCMRHVEKMC KADLSRNFIE RNHMENGGDH RYVNNYTNSF GGEWSAPDTM KRYSMYLTPK GGVRTSYQPS SPGRFTKETT QKNFNNLYGT KGNYTSRVWE YSSSIQNSDN DLPVVQGSSS FSLKGYPSLM RSQSPKAQPQ TWKSGKQTML SHYRPFYVNK GNGIGSNEAP
-
Réactivité croisée
- Humain, Souris, Rat
-
Attributs du produit
- Polyclonal Antibodies
-
Immunogène
- Recombinant fusion protein containing a sequence corresponding to amino acids 309-588 of human TRIM29 (NP_036233.2).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB,1:500 - 1:2000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- TRIM29 (Tripartite Motif Containing 29 (TRIM29))
-
Autre désignation
- TRIM29
-
Sujet
- The protein encoded by this gene belongs to the TRIM protein family. It has multiple zinc finger motifs and a leucine zipper motif. It has been proposed to form homo- or heterodimers which are involved in nucleic acid binding. Thus, it may act as a transcriptional regulatory factor involved in carcinogenesis and/or differentiation. It may also function in the suppression of radiosensitivity since it is associated with ataxia telangiectasia phenotype.,TRIM29,ATDC,Epigenetics & Nuclear Signaling,Transcription Factors,Cell Biology & Developmental Biology,Cell Cycle,Cell differentiation,TRIM29
-
Poids moléculaire
- 63 kDa/65 kDa
-
ID gène
- 23650
-
UniProt
- Q14134
-
Pathways
- Signalisation p53, Apoptose, Réparation de l'ADN, Inositol Metabolic Process, Positive Regulation of Response to DNA Damage Stimulus
Antigène
-